Predictors of oropharyngeal cancer survival in Europe

Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer J Int du Cancer, 136, E359, 10.1002/ijc.29210 Anantharaman, 2011, Population attributable risk of tobacco and alcohol for upper aerodigestive tract cancer, Oral Oncol, 47, 725, 10.1016/j.oraloncology.2011.05.004 Hashibe, 2009, Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium, Cancer Epidemiol Biomarkers Prev, 18, 541, 10.1158/1055-9965.EPI-08-0347 Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum. 2007;90:1–636. Ang, 2012, Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma, Semin Radiat Oncol, 22, 128, 10.1016/j.semradonc.2011.12.004 Chaturvedi, 2008, Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States, J Clin Oncol, 26, 612, 10.1200/JCO.2007.14.1713 Chaturvedi, 2011, Human papillomavirus and rising oropharyngeal cancer incidence in the United States, J Clin Oncol, 29, 4294, 10.1200/JCO.2011.36.4596 Mork, 2010, Time trends in pharyngeal cancer incidence in Norway 1981–2005: a subsite analysis based on a reabstraction and recoding of registered cases, Cancer Causes Control, 21, 1397, 10.1007/s10552-010-9567-9 Mehanna, 2010, Oropharyngeal carcinoma related to human papillomavirus, BMJ, 340, c1439, 10.1136/bmj.c1439 Huang, 2015, Refining American Joint Committee on Cancer/Union for International Cancer Control TNM stage and prognostic groups for human papillomavirus-related oropharyngeal carcinomas, J Clin Oncol, 33, 836, 10.1200/JCO.2014.58.6412 Ang, 2010, Human papillomavirus and survival of patients with oropharyngeal cancer, N Engl J Med, 363, 24, 10.1056/NEJMoa0912217 Lagiou, 2009, Alcohol-related cancers and genetic susceptibility in Europe: the ARCAGE project: study samples and data collection, Eur J Cancer Prev, 18, 76, 10.1097/CEJ.0b013e32830c8dca Lagiou, 2009, Diet and upper-aerodigestive tract cancer in Europe: the ARCAGE study, Int J Cancer, 124, 2671, 10.1002/ijc.24246 Ahrens, 2014, Oral health, dental care and mouthwash associated with upper aerodigestive tract cancer risk in Europe: the ARCAGE study, Oral Oncol, 50, 616, 10.1016/j.oraloncology.2014.03.001 Anantharaman, 2013, Human papillomavirus infections and upper aero-digestive tract cancers: the ARCAGE study, J Natl Cancer Inst, 105, 536, 10.1093/jnci/djt053 Waterboer, 2005, Multiplex human papillomavirus serology based on in situ-purified glutathione s-transferase fusion proteins, Clin Chem, 51, 1845, 10.1373/clinchem.2005.052381 Kreimer AR, Johansson M, Waterboer T, Kaaks R, Chang-Claude J, Drogen D, et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol. 2013. Lang Kuhs, 2015, Human papillomavirus 16 E6 antibodies in individuals without diagnosed cancer: a pooled analysis, Cancer Epidemiol Biomarkers Prev, 24, 683, 10.1158/1055-9965.EPI-14-1217 Ribeiro, 2011, Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions, Int J Epidemiol, 40, 489, 10.1093/ije/dyq249 Lang Kuhs, 2017, Human papillomavirus 16 E6 antibodies are sensitive for human papillomavirus-driven oropharyngeal cancer and are associated with recurrence, Cancer, 123, 4382, 10.1002/cncr.30966 Holzinger, 2017, Sensitivity and specificity of antibodies against HPV16 E6 and other early proteins for the detection of HPV16-driven oropharyngeal squamous cell carcinoma, Int J Cancer, 140, 2748, 10.1002/ijc.30697 Koo, 2009, J Transl Med, 7, 25, 10.1186/1479-5876-7-25 Singhi, 2010, Comparison of human papillomavirus in situ hybridization and p16 immunohistochemistry in the detection of human papillomavirus-associated head and neck cancer based on a prospective clinical experience, Cancer, 116, 2166 Smeets, 2007, A novel algorithm for reliable detection of human papillomavirus in paraffin embedded head and neck cancer specimen, Int J Cancer, 121, 2465, 10.1002/ijc.22980 Weinberger, 2006, Molecular classification identifies a subset of human papillomavirus–associated oropharyngeal cancers with favorable prognosis, J Clin Oncol, 24, 736, 10.1200/JCO.2004.00.3335 Schmitt, 2010, Abundance of multiple high-risk human papillomavirus (HPV) infections found in cervical cells analyzed by use of an ultrasensitive HPV genotyping assay, J Clin Microbiol, 48, 143, 10.1128/JCM.00991-09 Schwartz, 2001, Human papillomavirus infection and survival in oral squamous cell cancer: a population-based study, Otolaryngol Head Neck Surg, 125, 1, 10.1067/mhn.2001.116979 D'Souza, 2016, Effect of HPV on head and neck cancer patient survival, by region and tumor site: a comparison of 1362 cases across three continents, Oral Oncol, 62, 20, 10.1016/j.oraloncology.2016.09.005 Weinberger, 2004, Prognostic significance of p16 protein levels in oropharyngeal squamous cell cancer, Clin Cancer Res: Off J Am Assoc Cancer Res, 10, 5684, 10.1158/1078-0432.CCR-04-0448 Castellsague X, Alemany L, Quer M, Halec G, Quiros B, Tous S, et al. HPV Involvement in head and neck cancers: comprehensive assessment of biomarkers in 3680 patients. J Natl Cancer Institute. 2016;108:djv403. Dalianis, 2014, Human papillomavirus and oropharyngeal cancer, the epidemics, and significance of additional clinical biomarkers for prediction of response to therapy (Review), Int J Oncol, 44, 1799, 10.3892/ijo.2014.2355 Marur, 2010, HPV-associated head and neck cancer: a virus-related cancer epidemic, Lancet Oncol, 11, 781, 10.1016/S1470-2045(10)70017-6